The US Agency for International Development (USAID) supports the OPTIMIZE partnership, which aims to accelerate access to optimal ARVs. This consortium, led by Wits RHI in South Africa, brings together a diverse set of partners from research, manufacturing, market access, program implementation and community and advocacy engagement. OPTIMIZE members include ICAP at Columbia University, Mylan Laboratories, the University of Liverpool, and the Medicines Patent Pool.
OPTIMIZE builds on the technical leadership of USAID’s Center for Accelerating Innovation and Impact, which applies private sector approaches to the development, introduction and scale-up of health interventions. The Center's Idea to Impact Guide describes the Center's approach to introducing and scaling new global health innovations.